| Autor: |
Shupe MP; 1. Department of Hematology/Oncology., Graham LJ; 1. Department of Hematology/Oncology., Schneble EJ; 2. Department of Surgery., Flynt FL; 1. Department of Hematology/Oncology., Clemenshaw MN; 3. Department of Nuclear Medicine., Kirkpatrick AD; 4. Department of Diagnostic Radiology., Stojadinovic A; 5. Department of Surgical Oncology, San Antonio Military Medical Center (SAMMC), Brooke Army Medical Center, 3551 Roger Brooke Dr., Ft. Sam Houston, TX 78234, USA., Peoples GE; 6. Department of Surgical Oncology, Walter Reid National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, USA., Shumway NM; 1. Department of Hematology/Oncology. |
| Abstrakt: |
In the prior review, we outlined the current standard of care for monitoring treatment responses in breast cancer and discussed the many challenges associated with these strategies. We described the challenges faced in common clinical settings such as the adjuvant setting, neoadjuvant setting, and the metastatic setting. In this review, we will expand upon future directions meant to overcome several of these current challenges. We will also explore several new and promising methods under investigation to enhance how we monitor treatment responses in breast cancer. Furthermore, we will highlight several new technologies and techniques for monitoring breast cancer treatment in the adjuvant, neoadjuvant and metastatic setting. |
